302 related articles for article (PubMed ID: 33180318)
21. [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
Zhao Y; Tian X; Liu G
Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):33-6. PubMed ID: 26791921
[TBL] [Abstract][Full Text] [Related]
22. Caffeine controversies.
Gentle SJ; Travers CP; Carlo WA
Curr Opin Pediatr; 2018 Apr; 30(2):177-181. PubMed ID: 29346141
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous caffeine application in the treatment of neonatal apnoea.
Amato M; Isenschmid M; Hüppi P
Eur J Pediatr; 1991 Jun; 150(8):592-4. PubMed ID: 1954966
[TBL] [Abstract][Full Text] [Related]
24. A Randomized Controlled Trial Comparing Two Doses of Caffeine for Apnoea in Prematurity.
Mohd Kori AM; Van Rostenberghe H; Ibrahim NR; Yaacob NM; Nasir A
Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33922783
[TBL] [Abstract][Full Text] [Related]
25. Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
Koch G; Datta AN; Jost K; Schulzke SM; van den Anker J; Pfister M
J Pediatr; 2017 Dec; 191():50-56.e1. PubMed ID: 29173321
[TBL] [Abstract][Full Text] [Related]
26. Childhood respiratory outcomes after neonatal caffeine therapy.
Cheong JLY; Doyle LW
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101158. PubMed ID: 33127315
[TBL] [Abstract][Full Text] [Related]
27. Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.
Yu T; Balch AH; Ward RM; Korgenski EK; Sherwin CM
BMC Pharmacol Toxicol; 2016 Jun; 17(1):22. PubMed ID: 27266401
[TBL] [Abstract][Full Text] [Related]
28. Periextubation caffeine in preterm neonates: a randomized dose response trial.
Steer PA; Flenady VJ; Shearman A; Lee TC; Tudehope DI; Charles BG
J Paediatr Child Health; 2003; 39(7):511-5. PubMed ID: 12969204
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort study.
Yun WZ; Kassab YW; Yao LM; Khairuddin N; Ming LC; Hadi MA
Int J Clin Pharm; 2022 Oct; 44(5):1140-1148. PubMed ID: 35915341
[TBL] [Abstract][Full Text] [Related]
30. Methylxanthine treatment for apnoea in preterm infants.
Henderson-Smart DJ; De Paoli AG
Cochrane Database Syst Rev; 2010 Dec; (12):CD000140. PubMed ID: 21154343
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of the efficacy of domestic and imported caffeine citrate in the treatment of apnea in preterm infants: a prospective randomized double-blind controlled trial].
He T; Liao ZC; Ding Y; Wang MJ; Li W; Gan JM; Yue SJ
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):684-689. PubMed ID: 32669161
[TBL] [Abstract][Full Text] [Related]
32. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
[TBL] [Abstract][Full Text] [Related]
33. National and international guidelines for neonatal caffeine use: Are they evidenced-based?
Eichenwald EC
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101177. PubMed ID: 33214064
[TBL] [Abstract][Full Text] [Related]
34. Population pharmacokinetic study of caffeine citrate in Chinese premature infants with apnea.
Guo A; Zhu Z; Xue J; Di X; Fan J; Huang L; Zhao P; Hu X; Xie H
J Clin Pharm Ther; 2020 Dec; 45(6):1414-1421. PubMed ID: 32737938
[TBL] [Abstract][Full Text] [Related]
35. Caffeine and supplemental oxygen effectively suppress periodic breathing with only minor effects during long episodes of apnoea in preterm infants.
Seppä-Moilanen M; Andersson S; Rantakari K; Mikkola K; Kirjavainen T
Acta Paediatr; 2019 Mar; 108(3):443-451. PubMed ID: 30118174
[TBL] [Abstract][Full Text] [Related]
36. Developing and testing a clinical care bundle incorporating caffeine citrate to manage apnoea of prematurity in a resource-constrained setting: a mixed methods clinical feasibility study protocol.
Irimu G; Okwaro F; Coleman J; Waiyego M; Murila F; Chomba D; Parsimei M; Shitote C; Ochieng R; Shah J; Ogero M; Ginsburg AS; Ansermino JM; Macharia W
Implement Sci Commun; 2023 Jul; 4(1):80. PubMed ID: 37461120
[TBL] [Abstract][Full Text] [Related]
37. Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?
Saroha V; Patel RM
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101178. PubMed ID: 33168464
[TBL] [Abstract][Full Text] [Related]
38. The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity.
García-Robles A; Solaz-García Á; Verdú-Andrés J; Andrés JLP; Cañada-Martínez AJ; Pericás CC; Ponce-Rodriguez HD; Vento M; González PS
Eur J Pediatr; 2022 Dec; 181(12):4175-4182. PubMed ID: 36169712
[TBL] [Abstract][Full Text] [Related]
39. Predictors for poor daily weight gain in preterm neonates exposed to different dose regimens of caffeine in ICU- a retrospective cohort study.
Ahmed S; Rehman AU; Bibi Z; Iftikhar S; Raza M; Yousuf HMA; Naz F; Shah SAM; Mir SL; Bibi A; Khan WA; Salat MS; Ambreen G; Hussain K
BMC Pediatr; 2024 Jun; 24(1):401. PubMed ID: 38898410
[TBL] [Abstract][Full Text] [Related]
40. Serum caffeine concentrations in preterm infants: a retrospective study.
Sugino M; Kuboi T; Noguchi Y; Nishioka K; Tadatomo Y; Kawaguchi N; Sadamura T; Nakano A; Konishi Y; Koyano K; Nakamura S; Okada H; Itoh S; Kusaka T
Sci Rep; 2023 Jun; 13(1):10305. PubMed ID: 37365252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
